Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).

Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.

Welsh startup Amotio has raised £810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.